From the outset, the cast of the television series MASH was a solid ensemble of performers, led by Alan Alda, who consistently walked the show's tightrope between comedy and drama. Together, the ...

Altimmune (ALT) stock plunges as a Phase 2b trial for its experimental MASH therapy shows mixed results. Read more here.

Investing.com -- Altimmune, Inc. (NASDAQ: ALT) stock fell 37% after the company announced topline results from its IMPACT Phase 2b trial of pemvidutide for the treatment of metabolic dysfunction ...

Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 liver disease study.

Rivus’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the drug's muscle-sparing potential.

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), announced that the Committee for ...

Watch Haim Mash Addison Rae’s Banger “Headphones On” Up With Janet Jackson & Joni Mitchell In BBC Live Lounge News June 23, 2025 12:33 PM By Tom Breihan ...

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the best biotech stocks to invest in now. On June 20, Madrigal Pharmaceuticals moved closer to introducing the first treatment for metabolic ...

First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of ...

Eli Lilly's tirzepatide and Boehringer Ingelheim's survodutide grab the spotlight at EASL with new phase 2 data in metabolic dysfunction-associated steatohepatitis (MASH) ...

New for 2025 is Dragon's Tail – a space to offer some calm within Glastonbury’s late-night area with artwork by Edgar Phillips at its heart ...

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...